CIAM
CYTK icon

Caitong International Asset Management’s Cytokinetics CYTK Stock Holding History

Caitong International Asset Management’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-6
Closed -$381 – 2693
2025
Q4 		$381 Sell
6
-85
-93% -$5.29K ﹤0.01% 1518
2025
Q3 		$5K Buy
91
+31
+52% +$1.28K ﹤0.01% 1224
2025
Q2 		$1.98K Buy
60
+56
+1,400% +$1.95K ﹤0.01% 1388
2025
Q1 		$161 Sell
4
-453
-99% -$20.8K ﹤0.01% 1948
2024
Q4 		$21.5K Buy
+457
New +$23.7K 0.02% 772

Other funds holding CYTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Caitong International Asset Management's CYTK Position: Q1 2026 in Review

Caitong International Asset Management sold out of Cytokinetics (CYTK) in Q1 2026, closing a stake of 6 shares — an estimated $381 sold.

Caitong International Asset Management first reported a position in CYTK in Q4 2024 and held it in 5 quarters. The position peaked at $21.5K in Q4 2024. 440 funds tracked by Wall St. Rank hold CYTK as of Q1 2026.

  • Caitong International Asset Management reported no remaining Cytokinetics position as of Q1 2026 after selling out during the quarter.
  • Caitong International Asset Management sold 6 Cytokinetics shares in Q1 2026, an estimated $381.
  • Caitong International Asset Management first reported a position in Cytokinetics in Q4 2024 and held it in 5 quarters.
  • Caitong International Asset Management's Cytokinetics position peaked at $21.5K in Q4 2024.
  • 440 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.